Priya Garg
LightNews LightNews
banner
priyagargiddoc.bsky.social
Priya Garg
@priyagargiddoc.bsky.social
1.1K followers 410 following 37 posts
Infectious Diseases Physician. Clinician Researcher. Immunocompromised Host ID. Transplant ID.
@pmcc @ncic @wslhd
Music lover, keen photographer and proud girl mum. #MedSky #TxID #WomeninSTEM #IDSky #InfectionPrevention #IDOnc
Posts Replies Media Videos
Pinned
priyagargiddoc.bsky.social
Priya Garg @priyagargiddoc.bsky.social · Nov 13
Delighted to be early to the party (for once)! #IDSky #MedSky
ID Physician and clinician researcher in Melbourne, interested in Transplant-ID, Immunocompromised Host, Tropical Med & Infection Prevention. Excited to join the @bsky.app ID community 💪
Reposted by Priya Garg
mja.com.au
🔔 NEW in the Medical Journal of Australia

Prolonged SARS‐CoV‐2 shedding in a lung transplant recipient: time for flexibility in infection prevention?

✍️ Alyssa Pradhan, David Pham, Alexander Brennan, Jen Kok and Priya Garg

OPEN ACCESS https://buff.ly/42yLhDb
February 5, 2025 at 10:00 PM
Reposted by Priya Garg
ncicancer.bsky.social
Australia’s first multi-site study of infections in cancer & transplant patients, PROSPER, is now published in BMJ Open! It will guide future infection prevention & control for this vulnerable group.

Read the full article here: bmjopen.bmj.com/content/15/7...
September 5, 2025 at 5:57 AM
Reposted by Priya Garg
michyong.bsky.social
🔥🔥Just published in #CID world-first clinical trial of IFN-a nasal spray vs placebo reduced #COVID 🦠 incidence 📉 by 40% in cancer pts. Well tolerated, safe, effective…

Full link here: academic.oup.com/cid/advance-ar…
September 1, 2025 at 12:21 PM
priyagargiddoc.bsky.social
Always exciting to learn more about novel cellular therapies for IFIs at Westmead Hospital ID week! (And see all the research across the precinct) @westmeadinst.bsky.social #TxID
August 28, 2025 at 5:57 AM
priyagargiddoc.bsky.social
Pleased to publish the INTERACT study - describing current infection prevention & surveillance practice in the care of Australasian cancer/transplant patients & areas for future research (& thankful to all who participated) 🌟 @ncicancer.bsky.social #TxID #IDSky

www.ajicjournal.org/article/S019...
The INTERACT study: Infection prevention and surveillance practice in the care of the Australasian cancer and transplant population
Australasian cancer and transplant populations are expanding, with increased infection risk related to prolonged survivorship and broader use of novel immunosuppressants. To optimise care, standardise...
www.ajicjournal.org
August 12, 2025 at 9:06 PM
Reposted by Priya Garg
chelseagorsline.bsky.social
Our new @txidfellows.bsky.social paper is out! This one on ASP in #TxID. Practical tips for beginners and early career faculty. @courtharrismd.bsky.social @rebeccakumar.bsky.social @divsharma.bsky.social @mirandapharmdmph.bsky.social @hannah-imlay.bsky.social
absteward.bsky.social Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · Nov 25
🆕️🔥Article @thetxidjournal.bsky.social
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases
Table ✨️2: TID ASP opportunities & initiatives
#idsky #medsky #Txid
onlinelibrary.wiley.com/doi/full/10....
November 25, 2024 at 10:53 PM
Reposted by Priya Garg
benwteh.bsky.social
Delighted to have been part of these important ECiL-10 c diff guidelines specific to our haematology patients.
#TxID @ncicancer.bsky.social @ichs-global.bsky.social @theebmt.bsky.social

www.sciencedirect.com/science/arti...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
smex-ctp.trendmicro.com
August 8, 2025 at 4:11 AM
Reposted by Priya Garg
transplantidnet.bsky.social
[email protected] has #ID #HSCT #CAR-T guidelines in TCT Journal
transplantid.net "GUIDELINES"▶️ "ASTCT Guidelines"📁

#️⃣ 9️⃣ : Mgmt of HHV-6B after HSCT and CAR-T
Bonus: Tests for chromosomal integration!
Thanks Aneela Majeed @clevelandclinic.bsky.social!

transplantid.net/37V7X3QT
July 1, 2025 at 4:16 PM
priyagargiddoc.bsky.social
Excited to see what the PROSPER study (point prevalence of infections in cancer & transplant) demonstrates.. @ncicancer.bsky.social 🦠 @bmj.com #TxID #IDSky #EpiSky
Estimating the prevalence of key healthcare-associated and opportunistic infections in Australian transplant and cancer populations: protocol for the PROSPER point prevalence study
Introduction The immunocompromised host (ICH) is at increased risk for a range of opportunistic and healthcare-associated infections (OI/HAIs). With increased use of novel therapeutics and prolonged s...
bmjopen.bmj.com
August 1, 2025 at 9:52 PM
Reposted by Priya Garg
ncicancer.bsky.social
We were proud to be well represented at the inaugural The
Transplantation Society of Australia and New Zealand Infectious Disease Day on 20 June 2025 — a fantastic event co-badged with ASID Immunocompromised Host Special Interest Group.
June 27, 2025 at 5:39 AM
priyagargiddoc.bsky.social
Pleased to present our subgroup analysis @TSANZ. Would IPC specific to the SOT cohort be valuable? Which HAIs/OIs should we monitor, and how do we build a national framework for success? @ncicancer.bsky.social #TxID #IDSky
June 22, 2025 at 10:52 AM
priyagargiddoc.bsky.social
Always a pleasure to hear @aussiedocwolfe.bsky.social speak on advances in organ transplantation & thankful to chair a session on infection surveillance in transplant @TSANZ Transplant Infectious Disease day! Congrats to the committee for putting together an exciting inaugural meeting.
June 20, 2025 at 10:41 PM
Reposted by Priya Garg
vzhu1.bsky.social
Happy Infectious Diseases Pharmacists Day to my colleagues, mentors, and clinician-researcher heroes #IDPharmacistsDay #SIDPAdvocacy @adphaau.bsky.social @sidpharm.bsky.social @ncicancer.bsky.social
May 21, 2025 at 11:48 PM
priyagargiddoc.bsky.social
Grateful to have received a travel stipend to spend an exciting few days at the @fredhutch.bsky.social ICH Symposium in Seattle, present & learn from experts in the field- Including @kottonnelson.bsky.social, Jay Fishman & our own @ncicancer.bsky.social @michyong.bsky.social, Monica Slavin & more..!
May 15, 2025 at 12:34 AM
Reposted by Priya Garg
germhuntermd.bsky.social
Herpes Simplex Virus and Drug Resistance - Comprehensive Update on Resistance Mutations and Implications for Clinical Management: A Narrative Review

Open Access @cmijournal.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119... #IDSky #TxID
Figure 1 Overview of mechanisms of action of different drugs used in the treatment of infection with HSV-1/2. The nucleoside analogues ACV, PCV and BVDU are phosphorylated by viral TK. ACV-P, PCV-P, BVDU-P and CDV are biphosphorylated by cellular kinases. The phosphorylated compounds are then incorporated into nascent DNA. This leads to a stop in viral replication or, in case of BVDU, destabilizes the DNA and inhibits the replication. FOS inhibits replication by directly binding POL and inhibiting the pyrophosphate binding site competitively. AMNV and PTV bind to the viral helicase-primase complex. This inhibits DNA unwinding and therefore inhibits replication. ACV: aciclovir; PCV: penciclovir; BVDU: brivudine; CDV: cidofovir; FOS: foscarnet; AMNV: amenamevir; PTV: pritelivir.
May 9, 2025 at 4:18 PM
Reposted by Priya Garg
germhuntermd.bsky.social
Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies

Hyunah Yoon, Liise-anne Pirofsky, @drboulware.bsky.social

In non-HIV-associated CM, ⬇️ing immunosuppression --> ⬆️ inflammation --> 🧠 damage.

academic.oup.com/cid/advance-... #TxID #IDSky
A line graph illustrating immunosuppressive drug intensity and immune cell recovery (CD4+ T, B and NK cells) over months following kidney transplantation, highlighting a window of heightened cryptococcal disease risk. Two parabola diagrams comparing HIV-associated cryptococcal damage and non-HIV transplant-associated damage. In both settings, too little or too much immune response can result in host damage (left and right arms of the parabola). However, in non-HIV transplant patients, the overall position on the parabola is less predictable, due to the heterogeneous effects of immunosuppressive medications before and during cryptococcal infection.
April 26, 2025 at 12:47 AM
Reposted by Priya Garg
ichejournal.bsky.social
New from @loukasmd.bsky.social et al:

Authors provide systematic review of pathogens & sources of contamination linked to outbreaks in HSCT units

▶️ 39 studies, various sources including water, construction, contamination

#IDSky

📄: doi.org/10.1017/ice....
April 22, 2025 at 2:04 PM
Reposted by Priya Garg
absteward.bsky.social
The most anticipated RCT in ID
🔥SNAP RCT🔥The largest RCT 2 date in SA bactermia
N:1341
Cefazolin Vs ASPs ((flu)cloxacillin) for MSSA bacteremia
Cefazolin is non-inferior (90d mortality)& less AKI than ASPs
A practice-changer RCT that must change the guidelines
#ESCMIDGlobal #IDSky
April 12, 2025 at 3:09 PM
Reposted by Priya Garg
ncicancer.bsky.social
Day 2 of the Australasian Society for Infectious Diseases (ASID) ASM in Canberra, our incredible NCIC team proudly showcased their poster presentations. It was a fantastic opportunity to showcase their hard work and dedication to advancing the ICH space on a national stage!
April 4, 2025 at 5:54 AM
priyagargiddoc.bsky.social
Great to hear work by my friend, fellow ID physician & PhD candidate @dremmalouise.bsky.social & nursing student Jobe Bonney on tackling TB in remote communities at the ASID ASM - excited to hear how the REACT project progresses! @asidaud.bsky.social
April 4, 2025 at 6:26 AM
priyagargiddoc.bsky.social
Honoured to speak & present our @ncicancer.bsky.social work on infection prevention in cancer/transplant at the Australasian Society of ID ASM with @nikhil-singh.bsky.social @michyong.bsky.social @benwteh.bsky.social, & amazing to hear & see the incredible work done at other centres nationally 👏🏽
April 4, 2025 at 4:00 AM
Reposted by Priya Garg
ncicancer.bsky.social
Great 1st day at Australasian Society for Infectious Diseases meeting!

@michyong.bsky.social led an insightful CMV symposium

@benwteh.bsky.social chaired the "What's New in.." session as part of ICHSIG

@priyagargiddoc.bsky.social comprehensive talk on key developments and gaps in the ICHS space
April 3, 2025 at 11:01 PM
priyagargiddoc.bsky.social
Sad to have had my last ‘in-person’ day as a physician at the @petermaccc.bsky.social, Melbourne! A fantastic place to practice, be inspired in #IDOnc #TxID and surrounded by #womeninSTEM! Will continue my PhD through the @ncicancer.bsky.social though, so many more return visits to come 🙌🏽
March 14, 2025 at 7:17 AM
priyagargiddoc.bsky.social
Excited to receive some @ucla-id-fellowship.bsky.social merch in the post here in Melbourne to use on my next ward round! UCLA Transplant-ID; thank you again- a fabulous team & such great learnings/ collaborative discussions in the care of the high-risk ICH @jschaenmanmd.bsky.social #TxID #IDsky
March 12, 2025 at 1:38 AM
Reposted by Priya Garg
pharmageddon.bsky.social
Next draft Infection Card for Epipocalypse: Bug Detectives: Measles!

Unfortunately this is a thing again. Remember the 3 C's and to keep it in your differential!

#IDSky #MedSky #EpiSky any feedback or suggestions?
Measles.
February 26, 2025 at 12:57 AM